Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
Nexavar articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
MannKind Lands Afrezza Partner but at High Cost
... The classic example is the Bayer-Onyx Pharma joint venture to sell the cancer drug
. Onyx ended up hating that partnership -- and so did investors -- because real profits were...
Read more at TheStreet.com
Phase 3 trial: NEXAVAR tablets fail to meet prima...
Inc., an Amgen subsidiary (NASDAQ: AMGN), today announced that an investigational Phase 3 trial of
® (sorafenib) tablets in patients with advanced breast cancer did not meet its primary...
Read more at News-Medical-Net
Onyx Pharmaceuticals Inc.
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.